NEURO-ONCOLOGY FELLOWSHIP

About the Fellowship

Each year, a clinical researcher in neuro-oncology is invited to join the Brain Tumour Research Centre team for a year long Fellowship in paediatric brain tumour research. Funded by Meagan's Walk, the Fellowship advances research and fosters collaboration with international research institutions. Researchers continue to discover more and more subtypes of rare brain tumours. International partnerships built through the Fellowship program help researchers better understand these tumours and make progress in the development of targeted treatments and improved incomes.

In 2005, Meagan’s Walk established the Meagan Bebenek Endowment Fund, currently valued at over $2 Million. The annual investment return is approximately $95K and funds the Meagan’s Walk Neuro-Oncology Fellowship.

OUR FELLOWS

2014/15

DR. ALVARO LASSALETTA, SPAIN
Dr. Lassaletta evaluated the efficacy and feasibility of reirradiation (radiating again at relapse) in patients with DIPG, an incurable tumour.
Button
2015/16

DR. MICHAL ZAPOTOCKY, CZECH REP
Dr. Zapotocky evaluated incidents of mutations in low-grade gliomas with clinical outcomes to identify patients suitable for novel targeted therapies.
Button
2016/17

DR. CHRISTINE DAHL, DENMARK
Dr. Dahl investigated the cognitive outcome of children treated for medulloblastoma in relation to hearing impairment.
Button

2017/18

DR. LIANA NOBRE, BRAZIL
Studying the molecular characterization of low grade gliomas, Dr. Nobre explored the feasibility of liquid biopsy to better determine response to new targeted therapies.
Button
2018/19

DR. LORENA BARONI, ARGENTINA
Dedicated to understanding malignant brain tumours in the central nervous system, Dr. Baroni focuses her research on clinical management and treatment of high risk patients and clinical-biological correlations.
Button
2019/20

DR. ANIRBAN DAS, INDIA
Dr Das is currently focussing his research on an increasingly recognised cancer predisposition syndrome for children with brain tumours, known as the Constitutional Mismatch Repair Deficiency Syndrome (CMMRD), where tumours do not get cured by traditional chemo and radiotherapy approaches.
Button